triazoles has been researched along with Ventricular Dysfunction in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, RJ; Beck, SE; Bedja, D; Graham, DR; Kelly, KM; Lyashkov, A; Mankowski, JL; Metcalf Pate, KA; Paolocci, N; Queen, SE; Tarwater, PM; Tocchetti, CG | 1 |
Herbrecht, R; Kemmel, V; Levêque, D; Nivoix, Y; Scholler, J | 1 |
2 other study(ies) available for triazoles and Ventricular Dysfunction
Article | Year |
---|---|
CCR5 inhibition prevents cardiac dysfunction in the SIV/macaque model of HIV.
Topics: Animals; CCR5 Receptor Antagonists; Cyclohexanes; Diastole; Disease Models, Animal; Echocardiography, Doppler; Heart Ventricles; HIV Fusion Inhibitors; Ligands; Macaca mulatta; Maraviroc; Myocytes, Cardiac; Receptors, CCR5; Signal Transduction; Simian Acquired Immunodeficiency Syndrome; Triazoles; Ventricular Dysfunction; Ventricular Function; Viral Load | 2014 |
Ventricular bigeminy associated with voriconazole, methadone and esomeprazole.
Topics: Adult; Analgesics, Opioid; Antifungal Agents; Arrhythmias, Cardiac; Drug Interactions; Esomeprazole; Female; Humans; Methadone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proton Pump Inhibitors; Pyrimidines; Triazoles; Ventricular Dysfunction; Voriconazole | 2011 |